🔬Anthropic Acquires Coefficient Bio for $400M in AI-Bio Talent Grab
Anthropic Acquires Coefficient Bio for $400M in AI-Bio Tale…
TL;DR
Anthropic acquired Coefficient Bio, an eight-month-old startup founded by former Evozyne, Genentech, and Prescient Design computational biologists, for $400 mi…
Anthropic acquired Coefficient Bio, an eight-month-old startup founded by former Evozyne, Genentech, and Prescient Design computational biologists, for $400 million in stock. The deal signals Anthropic's move into AI-for-biology as a core vertical.
Key Points
$400M all-stock transaction
Team sourced from Evozyne, Genentech, Prescient Design
Anthropic's most explicit biotech move to date
Deal closed earlier this month
Why It Matters
Anthropic is following OpenAI into pharma, setting up a two-way frontier model race for the high-margin drug discovery market.
Frequently Asked Questions
Why does this matter?
Anthropic is following OpenAI into pharma, setting up a two-way frontier model race for the high-margin drug discovery market.
What happened?
Anthropic acquired Coefficient Bio, an eight-month-old startup founded by former Evozyne, Genentech, and Prescient Design computational biologists, for $400 mi…
Comments
Be the first to comment
Enjoyed this article?
Get the top stories delivered to your inbox every morning. Free.